Clinical Trials

Infectious Disease

COVID-19

Study of Sargramostim in Patients With COVID-19 (iLeukPulm)

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Using GM-CSF as a Host Directed Therapeutic Against COVID-19

Cancer

Hematologic Malignancies

GM-CSF With Post-Transplant Cyclophosphamide

Melanoma

Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Biliary Cancer

Pembrolizumab and GM-CSF in Biliary Cancer

Neurology

Parkinson’s disease

Biomarker Assessments of Leukine During Treatment of Parkinson’s Disease

Note: Not all clinical trials including sargramostim are listed.